BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9588765)

  • 1. Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
    Tassopoulos NC
    Liver; 1998 Apr; 18(2):71-2. PubMed ID: 9588765
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
    Wolters LM; Hansen BE; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1007-11. PubMed ID: 12352221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy for hepatitis B.
    Di Bisceglie AM
    Gut; 2002 Apr; 50(4):443-5. PubMed ID: 11889057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside analogues for chronic hepatitis B.
    Wolters LM; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1499-506. PubMed ID: 11742201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
    Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current treatment of hepatitis B].
    Suárez García E; Romero Gómez M; Grande Santamaría L
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic viral hepatitis.
    Main J; McCarron B; Thomas HC
    Antivir Chem Chemother; 1998 Nov; 9(6):449-60. PubMed ID: 9865383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How will we use the new antiviral agents for hepatitis B?
    Perrillo RP
    Curr Gastroenterol Rep; 2002 Feb; 4(1):63-71. PubMed ID: 11825543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV; Dimou E; Papadimitropoulos V
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
    Fried MW; Sommadossi JP
    Antivir Ther; 1996 Apr; 1(2):71-6. PubMed ID: 11321182
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
    Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B infection in China.
    Lau GK
    Clin Liver Dis; 2001 May; 5(2):361-79. PubMed ID: 11385968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Famciclovir treatment of patients with chronic hepatitis B virus infection].
    Li L; Shao Q; Zhang J; Ji D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):390-1. PubMed ID: 12665916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different treatment combinations for chronic hepatitis B infection.
    Demirtürk N; Usluer G; Ozgünes I; Colak H; Kartal ED; Dinçer S
    J Chemother; 2002 Jun; 14(3):285-9. PubMed ID: 12120884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
    Sangfelt P; Uhnoo I; Hollander A; Lindh G; Weiland O
    Scand J Infect Dis; 2002; 34(7):505-11. PubMed ID: 12195876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA
    Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
    Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
    Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.